A phase 1 study of orally administered 5-fluoro-2'-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors
一项针对难治性实体瘤患者的口服5-氟-2'-脱氧胞苷联合四氢尿苷的I期研究
期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-025-04844-y
Chen, Alice P; Kummar, Shivaani; Rubinstein, Larry; Zlott, Jennifer; Coyne, Geraldine O'Sullivan; Chung, Vincent; Newman, Edward M; Lenz, Heinz-Josef; Kelly, Karen; Villaruz, Liza C; Konaté, Mariam M; Ferry-Galow, Katherine V; Wang, Lihua; Kinders, Robert J; Parchment, Ralph E; Covey, Joseph M; Holleran, Julianne L; Piekarz, Richard L; Miller, Sarah B; Juwara, Lamin; Beumer, Jan H; Doroshow, James H